Total Raised

$31.93M

Investors Count

7

Funding, Valuation & Revenue

11 Fundings

Primrose Bio has raised $31.93M over 11 rounds.

Primrose Bio's latest funding round was a Series B for $15M on June 18, 2024.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/18/2024

Series B

$15M

1315 Capital

$XXM

0

FY undefined

3

9/18/2023

Series A

$15M

$XXM

0

FY undefined

4

7/1/2019

Grant - II

$0.2M

$XXM

0

FY undefined

1

6/20/2019

Grant

$XXM

$XXM

0

FY undefined

10

3/14/2019

Incubator/Accelerator - II

$XXM

0

FY undefined

10

Date

6/18/2024

9/18/2023

7/1/2019

6/20/2019

3/14/2019

Round

Series B

Series A

Grant - II

Grant

Incubator/Accelerator - II

Amount

$15M

$15M

$0.2M

$XXM

Investors

1315 Capital

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

3

4

1

10

10

Start free trial
New call-to-action

Primrose Bio Investors

7 Investors

Primrose Bio has 7 investors. 1315 Capital invested in Primrose Bio's Series B funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/18/2024

6/18/2024

1315 Capital
1
Series B

Private Equity

Pennsylvania

00/00/0000

00/00/0000

Ligand Pharmaceuticals

Subscribe to see more

Corporation

California

00/00/0000

00/00/0000

U.S. Department of Energy

Subscribe to see more

Government

DC

00/00/0000

00/00/0000

U.S. Department of Agriculture

Subscribe to see more

Government

DC

00/00/0000

00/00/0000

Plug and Play

Subscribe to see more

Incubator/Accelerator

First funding

6/18/2024

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

6/18/2024

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

1315 Capital

Ligand Pharmaceuticals

U.S. Department of Energy

U.S. Department of Agriculture

Plug and Play

Rounds

1
Series B

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Private Equity

Corporation

Government

Government

Incubator/Accelerator

Location

Pennsylvania

California

DC

DC

Primrose Bio Acquisitions

1 Acquisition

Primrose Bio acquired 1 company. Their latest acquisition was Pelican Expression Technology on September 18, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/18/2023

$XXM

Merger

5

Date

9/18/2023

Investment Stage

Companies

Valuation

$XXM

Total Funding

Note

Merger

Sources

5

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.